Decibel Therapeutics, Inc. Common Stock
DBTX
DBTX was delisted on the 22nd of September, 2023.
54 hedge funds and large institutions have $226M invested in Decibel Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 54 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$77.6M |
| 2 |
TGI
TRV GP III
Boston,
Massachusetts
|
+$49.3M |
| 3 |
BlackRock
New York
|
+$33.8M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$27.9M |
| 5 |
AI
Alphabet Inc
Mountain View,
California
|
+$25.7M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIP
51
Ameritas Investment Partners
Lincoln,
Nebraska
| $7K | +$9.1K | +580 | New |
|
52
Citigroup
New York
| $5K | +$7.44K | +474 | New |
|
53
Bank of Montreal
Toronto,
Ontario, Canada
| $3K | +$3.89K | +248 | New |
|
|
AIG
54
American International Group
New York
| $47 | +$65.2K | +4,155 | New |
|
DBTX Hedge Fund Activity: Q1 2021 in Review
54 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Decibel Therapeutics, Inc. Common Stock (DBTX) for Q1 2021, worth a combined $226M.
Buyers outnumbered sellers: 54 funds opened new DBTX positions and 0 closed out — a net gain of 54 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $77.6M.
- 54 institutional investors held Decibel Therapeutics, Inc. Common Stock (DBTX) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $226M of Decibel Therapeutics, Inc. Common Stock stock for Q1 2021.
- 54 funds opened new Decibel Therapeutics, Inc. Common Stock positions in Q1 2021 and 0 closed out, a net change of +54 holders.
- The largest Decibel Therapeutics, Inc. Common Stock buyer in Q1 2021 was OrbiMed, an estimated $77.6M added.
Based on aggregated 13F filings for Q1 2021.